Drug Manufacturers - General Industry

Members of Parliament invested in the Drug Manufacturers - General Industry

55 investments

11 companies

Investors

Filed	Name	Company	Pur. £	Cur. £	P/L %	MPV*
Apr '12	Lord Glendonbrook	Astrazeneca / LSE:AZN.L	£2,666.50	£13,578.00	409.21%	£356,444.78
Apr '10	Baroness Noakes	Astrazeneca / LSE:AZN.L	£2,938.00	£13,578.00	362.15%	£323,505.79
Mar '14	Viscount Eccles	Astrazeneca / LSE:AZN.L	£3,876.50	£15,316.00	295.10%	£276,569.07**
Feb '11	Lord Wasserman	Johnson & Johnson / NYQ:JNJ	£60.93	£238.33	291.15%	£273,807.65
Dec '16	Lord Burns	Astrazeneca / LSE:AZN.L	£4,116.00	£13,578.00	229.88%	£230,918.37
Jan '13	Lord Sassoon	Johnson & Johnson / NYQ:JNJ	£72.69	£238.33	227.87%	£229,510.24
May '11	Lord Glendonbrook	Novartis / NYQ:NVS	£54.04	£153.92	184.82%	£199,373.74
May '18	Lord Grabiner	Astrazeneca / LSE:AZN.L	£5,417.00	£13,578.00	150.66%	£175,458.74
Apr '17	Lord Donoughue	Novartis / NYQ:NVS	£66.05	£153.92	133.04%	£163,128.89
Sep '16	Lord Gadhia	Astrazeneca / LSE:AZN.L	£5,099.00	£10,024.00	96.59%	£137,611.30**
Jul '16	Lord Lloyd-Webber	Johnson & Johnson / NYQ:JNJ	£122.64	£238.33	94.33%	£136,033.11
Feb '21	Lord Etherton	Astrazeneca / LSE:AZN.L	£7,422.00	£13,578.00	82.94%	£128,059.82
Nov '23	Lord Mance	Eli Lilly Co / VIE:LLYC.VI	£557.00	£1,010.00	81.33%	£126,929.98
Apr '21	Baroness Deech	Novartis / NYQ:NVS	£88.38	£153.92	74.16%	£121,909.94
Jun '21	Lord Morse	Astrazeneca / LSE:AZN.L	£8,005.00	£13,578.00	69.62%	£118,733.29
Aug '14	Lord Carter of Coles	Johnson & Johnson / NYQ:JNJ	£100.16	£161.55	61.29%	£112,904.35**
Apr '24	Lord Mendoza	Eli Lilly / NYQ:LLY	£731.33	£1,160.95	58.75%	£111,121.51
Mar '25	Lord Fink	Johnson & Johnson / NYQ:JNJ	£161.72	£238.33	47.37%	£103,160.40
May '23	Lord Fink	Johnson & Johnson / NYQ:JNJ	£165.03	£238.33	44.42%	£101,091.32
May '25	Lord Hayward	Glaxosmithkline / NYQ:GSK	£37.37	£52.86	41.45%	£99,015.26
Dec '16	Lord Burns	Glaxosmithkline / NYQ:GSK	£37.39	£52.86	41.37%	£98,962.29
May '24	Lord Goldsmith	Abbvie / NYQ:ABBV	£160.81	£224.77	39.77%	£97,841.56
May '20	Lord Deighton	Astrazeneca / LSE:AZN.L	£8,361.00	£11,236.00	34.39%	£94,070.09**
Apr '10	Lord Levene of Portsoken	Glaxosmithkline / NYQ:GSK	£39.38	£52.86	34.23%	£93,961.40
May '11	Lord Glendonbrook	Pfizer / NYQ:PFE	£19.54	£26.17	33.90%	£93,729.25
Apr '10	Baroness Noakes	Glaxosmithkline / NYQ:GSK	£39.49	£52.86	33.86%	£93,699.67
Nov '23	Lord Mance	Astrazeneca / LSE:AZN.L	£10,230.00	£13,578.00	32.73%	£92,909.09
Jan '24	Lord Fink	Roche / EBS:ROG.SW	£251.85	£321.70	27.73%	£89,414.34
Apr '17	Lord Leigh of Hurley	Roche / EBS:ROG.SW	£255.80	£321.70	25.76%	£88,033.62
Mar '17	Lord Lloyd-Webber	Glaxosmithkline / NYQ:GSK	£42.31	£52.86	24.94%	£87,454.50
May '11	Lord Glendonbrook	Glaxosmithkline / NYQ:GSK	£42.78	£52.86	23.56%	£86,493.69
Apr '26	Lord Grabiner	Eli Lilly / NYQ:LLY	£955.19	£1,160.95	21.54%	£85,078.88
May '24	Lord Balfe	Glaxosmithkline / NYQ:GSK	£44.02	£52.86	20.08%	£84,057.25
Aug '17	Lord Sterling of Plaistow	Johnson & Johnson / NYQ:JNJ	£133.45	£157.98	18.38%	£82,866.99**
Jan '13	Lord Sassoon	Glaxosmithkline / NYQ:GSK	£44.75	£52.86	18.12%	£82,686.03
May '23	Lord Fink	Astrazeneca / LSE:AZN.L	£11,774.00	£13,578.00	15.32%	£80,725.33
May '23	Lord Londesborough	Astrazeneca / LSE:AZN.L	£11,924.00	£13,578.00	13.87%	£79,709.83
Apr '24	Lord Balfe	Astrazeneca / LSE:AZN.L	£12,024.00	£13,578.00	12.92%	£79,046.91
Apr '23	Lord Grabiner	Novartis / NYQ:NVS	£95.80	£107.52	12.23%	£78,563.67**
May '24	Lord Goldsmith	Astrazeneca / LSE:AZN.L	£12,156.00	£13,578.00	11.70%	£78,188.55
Apr '21	Lord Farmer	Glaxosmithkline / NYQ:GSK	£36.65	£40.88	11.54%	£78,079.12**
Oct '20	Lord Taverne	Glaxosmithkline / NYQ:GSK	£37.57	£40.95	9.00%	£76,297.58**
Mar '25	Lord Fink	Roche / EBS:ROG.SW	£303.00	£321.70	6.17%	£74,320.13
Mar '14	Baroness Eccles of Moulton	Glaxosmithkline / NYQ:GSK	£53.43	£56.69	6.10%	£74,271.01**
May '23	Lord Leitch	Astrazeneca / LSE:AZN.L	£11,820.00	£12,340.00	4.40%	£73,079.53**
Nov '25	Lord Green of Hurstpierpoint	Roche / EBS:ROG.SW	£309.00	£321.70	4.11%	£72,877.03
Apr '21	Lord Grabiner	Roche / EBS:ROG.SW	£309.65	£321.70	3.89%	£72,724.05
Feb '25	Lord Green of Hurstpierpoint	Roche / EBS:ROG.SW	£285.70	£272.40	-4.66%	£66,741.33**
Feb '16	Lord Lloyd-Webber	Pfizer / NYQ:PFE	£29.02	£26.17	-9.83%	£63,119.41
Jan '20	Lord Gadhia	Glaxosmithkline / NYQ:GSK	£46.50	£40.95	-11.94%	£61,645.16**
Apr '22	Lord Cromwell	Johnson & Johnson / NYQ:JNJ	£179.90	£154.37	-14.19%	£60,066.15**
May '23	Lord Reay	Sanofi / NMS:SNY	£55.11	£47.22	-14.32%	£59,978.23**
Aug '16	Lord Lloyd-Webber	Eli Lilly / NYQ:LLY	£80.55	£67.15	-16.64%	£58,355.06**
Aug '20	Lord Reay	Roche / EBS:ROG.SW	£315.05	£249.80	-20.71%	£55,502.30**
Jul '18	Lord Glendonbrook	Bayer / GER:BAYN.DE	£95.26	£35.79	-62.43%	£26,299.60

* Minimum Potential Value based on £70,000.00 invested at time of declaration.

** Interest ceased/exited on filed date.